Macular degeneration articles within Scientific Reports

Featured

• Article
  31 May 2024 | Open Access

  The effect of duration between sessions on microperimetric biofeedback training in patients with maculopathies

  • Jie Zhou
  • , Jintong Hou
  •  & Jinglin Zhang

• Article
  21 May 2024 | Open Access

  Theoretical prediction of broadband ambient light optogenetic vision restoration with ChRmine and its mutants

  • Himanshu Bansal
  • , Gur Pyari
  •  & Sukhdev Roy

• Article
  26 April 2024 | Open Access

  Retinal and choroidal efficacy of switching treatment to faricimab in recalcitrant neovascular age related macular degeneration

  • Franziska Eckardt
  • , Anna Lorger
  •  & Jakob Siedlecki

• Article
  29 March 2024 | Open Access

  The impact of substrate stiffness on morphological, transcriptional and functional aspects in RPE

  • Lasse Wolfram
  • , Clara Gimpel
  •  & Günther Schlunck

• Article
  30 January 2024 | Open Access

  One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients

  • Satoru Inoda
  • , Hidenori Takahashi
  •  & Yasuo Yanagi

• Article
  10 January 2024 | Open Access

  Predicting treatment outcomes of intravitreal brolucizumab for polypoidal choroidal vasculopathy through noninvasive assessment of polypoidal lesion blood flow with optical coherence tomography angiography

  • Junki Hoshino
  • , Hidetaka Matsumoto
  •  & Hideo Akiyama

• Article
  19 December 2023 | Open Access

  Effects of donor-specific microvascular anatomy on hemodynamic perfusion in human choriocapillaris

  • Senyou An
  • , Huidan Yu
  •  & Bradley D. Gelfand

• Article
  14 December 2023 | Open Access

  Evaluation of a mobile app for dark adaptation measurement in individuals with age-related macular degeneration

  • Shrinivas Pundlik
  • , Prerana Shivshanker
  •  & Deeba Husain

• Article
  08 December 2023 | Open Access

  Retinal sensitivity and fundus autofluorescence in adult-onset foveomacular vitelliform dystrophy

  • Ryosuke Fujino
  • , Tatsuya Inoue
  •  & Ryo Asaoka

• Article
  30 November 2023 | Open Access

  Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration

  • Ryosuke Tamiya
  • , Masayuki Hata
  •  & Akitaka Tsujikawa

• Article
  30 November 2023 | Open Access

  Oxidative stress and docosahexaenoic acid injury lead to increased necroptosis and ferroptosis in retinal pigment epithelium

  • Almar Neiteler
  • , Anwar A. Palakkan
  •  & James A. Ross

• Article
  14 November 2023 | Open Access

  Attenuation of irradiated choroid and its regional vortex veins in central serous chorioretinopathy after photodynamic therapy

  • Hidetaka Matsumoto
  • , Junki Hoshino
  •  & Hideo Akiyama

• Article
  09 November 2023 | Open Access

  Automated deep learning-based AMD detection and staging in real-world OCT datasets (PINNACLE study report 5)

  • Oliver Leingang
  • , Sophie Riedl
  •  & Hrvoje Bogunović

• Article
  09 November 2023 | Open Access

  Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment

  • Hamid Riazi-Esfahani
  • , Esmaeil Asadi Khameneh
  •  & Elias Khalili Pour

• Article
  08 November 2023 | Open Access

  Complement factor H Y402H polymorphism results in diminishing CD4⁺ T cells and increasing C-reactive protein in plasma

  • Marie Krogh Nielsen
  • , Yousif Subhi
  •  & Carsten Faber

• Article
  08 September 2023 | Open Access

  Clinical outcomes in neovascular age-related macular degeneration: a cohort study of patients with care delay due to the COVID-19 pandemic

  • Timothy M. Janetos
  • , Roya Zandi
  •  & Manjot Gill

• Article
  06 July 2023 | Open Access

  Attitudes of potential recipients toward emerging visual prosthesis technologies

  • Vicky Karadima
  • , Elizabeth A. Pezaris
  •  & John S. Pezaris

• Article
  05 July 2023 | Open Access

  Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy

  • Naomi Nishigori
  • , Yuki Muraoka
  •  & Akitaka Tsujikawa

• Article
  19 June 2023 | Open Access

  Effect of fenestrated sterile drape and face mask on bacterial dispersion toward the periocular area during intravitreal injection

  • Nopasak Phasukkijwatana
  • , Rawi Jongpipatchai
  •  & Supalert Prakhunhungsit

• Article
  24 May 2023 | Open Access

  Multimodal imaging of laser-induced choroidal neovascularization in pigmented rabbits

  • Van Phuc Nguyen
  • , Jessica Henry
  •  & Yannis M. Paulus

• Article
  22 May 2023 | Open Access

  Deep learning to detect macular atrophy in wet age-related macular degeneration using optical coherence tomography

  • Wei Wei
  • , Joshua Southern
  •  & Kirill Veselkov

• Article
  19 May 2023 | Open Access

  Accurate drusen segmentation in optical coherence tomography via order-constrained regression of retinal layer heights

  • Olivier Morelle
  • , Maximilian W. M. Wintergerst
  •  & Thomas Schultz

• Article
  24 April 2023 | Open Access

  Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness

  • Sung Yeon Jun
  •  & Daniel Duck-Jin Hwang

• Article
  19 April 2023 | Open Access

  Clinical implications of choroidal vascular brightness using ultra-widefield indocyanine green angiography in polypoidal choroidal vasculopathy

  • Areum Jeong
  • , Xue Yao
  •  & Min Sagong

• Article
  06 April 2023 | Open Access

  Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network

  • Sehwan Moon
  • , Youngsuk Lee
  •  & Jae Hui Kim

• Article
  31 March 2023 | Open Access

  Elevated number and density of macrophage-like cell as a novel inflammation biomarker in diabetic macular edema

  • Zongyi Wang
  • , Haiyan An
  •  & Jinfeng Qu

• Article
  27 March 2023 | Open Access

  Assessing the structure of the posterior visual pathway in bilateral macular degeneration

  • Holly D. H. Brown
  • , Richard P. Gale
  •  & Antony B. Morland

• Article
  14 March 2023 | Open Access

  A laser-induced mouse model of progressive retinal degeneration with central sparing displays features of parafoveal geographic atrophy

  • Adnan H. Khan
  • , Sudha Priya Soundara Pandi
  •  & Andrew J. Lotery

• Article
  24 February 2023 | Open Access

  Two-year outcomes of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization

  • Hidetaka Matsumoto
  • , Junki Hoshino
  •  & Hideo Akiyama

• Article
  23 February 2023 | Open Access

  The effect of a brief, unplanned treatment delay on neovascular age-related macular degeneration patients: a retrospective cohort study

  • Jason Adam Zehden
  • , Arko Ghosh
  •  & Alice Yang Zhang

• Article
  23 February 2023 | Open Access

  A CRISPR-Cas9-mediated F0 screen to identify pro-regenerative genes in the zebrafish retinal pigment epithelium

  • Fangfang Lu
  • , Lyndsay L. Leach
  •  & Jeffrey M. Gross

• Article
  01 February 2023 | Open Access

  Quantitative multimodal imaging of extensive macular atrophy with pseudodrusen and geographic atrophy with diffuse trickling pattern

  • Alessio Antropoli
  • , Alessandro Arrigo
  •  & Maurizio Battaglia Parodi

• Article
  31 January 2023 | Open Access

  PRMT5 is a therapeutic target in choroidal neovascularization

  • Anbukkarasi Muniyandi
  • , Matthew Martin
  •  & Timothy W. Corson

• Article
  23 January 2023 | Open Access

  Aqueous microRNA profiling in age-related macular degeneration and polypoidal choroidal vasculopathy by next-generation sequencing

  • Yeong A. Choi
  • , Areum Jeong
  •  & Min Sagong

• Article
  20 January 2023 | Open Access

  Association of IL-4 with pachychoroid neovasculopathy

  • Takashi Baba
  • , Ayumi Koyama
  •  & Dai Miyazaki

• Article
  10 January 2023 | Open Access

  A vision transformer architecture for the automated segmentation of retinal lesions in spectral domain optical coherence tomography images

  • Daniel Philippi
  • , Kai Rothaus
  •  & Mauro Castelli

• Article
  05 January 2023 | Open Access

  Increased end-stage renal disease risk in age-related macular degeneration: a nationwide cohort study with 10-year follow-up

  • Wonyoung Jung
  • , Junhee Park
  •  & Dong Wook Shin

• Article
  29 December 2022 | Open Access

  Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization

  • Jae Hui Kim
  • , Jong Woo Kim
  •  & Chul Gu Kim

• Article
  26 December 2022 | Open Access

  Longitudinal change of reticular pseudodrusen area in ultrawide-field imaging

  • Je Moon Yoon
  • , Young Joo Choi
  •  & Don-Il Ham

• Article
  22 December 2022 | Open Access

  Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator

  • Maasa Ogata
  • , Hideyasu Oh
  •  & Miou Hirose

• Article
  18 November 2022 | Open Access

  The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration

  • Ki Woong Bae
  • , Dong Ik Kim
  •  & Daniel Duck-Jin Hwang

• Article
  05 November 2022 | Open Access

  Lipid profile and future risk of exudative age-related macular degeneration development: a nationwide cohort study from South Korea

  • Sungsoon Hwang
  • , Se Woong Kang
  •  & Sang Jin Kim

• Article
  01 November 2022 | Open Access

  Characteristics of intermediate age-related macular degeneration with hyperreflective foci

  • Wataru Kikushima
  • , Yoichi Sakurada
  •  & Kenji Kashiwagi

• Article
  28 October 2022 | Open Access

  Incidence of severe rise in intraocular pressure after intravitreous injection of aflibercept with prefilled syringes

  • Vita Louisa Sophie Dingerkus
  • , Gabor Mark Somfai
  •  & Florian Moritz Heussen

• Article
  11 October 2022 | Open Access

  Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking

  • Etsuyo Horiguchi
  • , Jun Takeuchi
  •  & Keiko Kataoka

• Article
  19 September 2022 | Open Access

  Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission

  • Han Joo Cho
  • , Young Joon Jeon
  •  & Jong Woo Kim

• Article
  08 September 2022 | Open Access

  Increased probability of mood disorders after age-related macular degeneration: a population-based cohort study

  • Chia-Yi Lee
  • , Hung-Chi Chen
  •  & Wei-Chi Wu

• Article
  01 September 2022 | Open Access

  Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy

  • Yongseok Mun
  • , Kyu Hyung Park
  •  & Se Joon Woo

• Article
  30 August 2022 | Open Access

  Recurrence of neovascular age-related macular degeneration after cessation of treat and extend regimen

  • Yuki Hirata
  • , Akio Oishi
  •  & Takashi Kitaoka

• Article
  20 August 2022 | Open Access

  Quantitative action spectroscopy reveals ARPE19 sensitivity to ultraviolet radiation at 350 nm and 380 nm

  • Graham Anderson
  • , Andrew McLeod
  •  & Baljean Dhillon